NasdaqCM - Nasdaq Real Time Price USD
Aligos Therapeutics, Inc. (ALGS)
5.94
+0.26
+(4.58%)
At close: May 13 at 4:00:01 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 638.45k | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
NUECHTERLEIN CAROLE L Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.76 per share. | Indirect | 6,004,149 | Oct 25, 2023 |
SCOPA JAMES PAUL Director | Stock Award(Grant) at price 0.76 per share. | Direct | 138,557 | Oct 25, 2023 |
BLATT LAWRENCE M Chief Executive Officer | Stock Award(Grant) at price 0.76 per share. | Direct | 461,858 | Oct 25, 2023 |
Related Tickers
CLDI Calidi Biotherapeutics, Inc.
0.4370
-1.53%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.8343
+7.40%
ASMB Assembly Biosciences, Inc.
12.34
-0.08%
SGMT Sagimet Biosciences Inc.
3.1800
-3.93%
BIVI BioVie Inc.
1.0700
-6.96%
FDMT 4D Molecular Therapeutics, Inc.
3.2700
-1.51%
CNTB Connect Biopharma Holdings Limited
0.7610
-5.17%
ITOS iTeos Therapeutics, Inc.
7.85
+13.44%
CTMX CytomX Therapeutics, Inc.
2.5000
+17.37%
VTYX Ventyx Biosciences, Inc.
1.2000
-0.83%